Library Subscription: Guest
Journal of Long-Term Effects of Medical Implants

Published 4 issues per year

ISSN Print: 1050-6934

ISSN Online: 1940-4379

SJR: 0.184 SNIP: 0.485 CiteScore™:: 1.1 H-Index: 39

Indexed in

Breast Cancer and Ovarian Cancer Genetics

Volume 15, Issue 5, 2005, pp. 533-545
DOI: 10.1615/JLongTermEffMedImplants.v15.i5.60
Get accessGet access

ABSTRACT

Breast and ovarian cancers are the second and fifth leading causes of cancer death, respectively, among women in the United States. Individuals with breast cancer have a 20-30% chance of having at least one relative with the disease. However, only 5-10% of the cases are a direct result of germline mutations in highly penetrable genes, such as BRCA1 and BRCA2 (BRCA1/2) as well as genes TP53 and PTEN. Since 1996, genetic testing for these mutations has been clinically available. A strategy for the management of women at increased familial risk of breast and ovarian cancers is described, which includes genetic assessment, chemoprevention, radiologic screening, and clinical and self-examination. Genetic testing should occur within a cancer genetic clinic after genetic counseling. A blood sample allows determination of the presence of the BRCA1 and BRCA2 genes, the TP53 gene, the PTEN gene, and the ATM gene. Tumor examination has identified a growth factor receptor gene, human epidermal growth factor receptor (HER-2).
With regard to diet and lifestyle, women at increased risk of breast cancer could be advised to reduce dietary fat, avoid obesity, decrease alcohol consumption, and take regular exercise. Although chemoprotection is a valuable consideration, it is important to emphasize that the use of Tamoxifen in BRCA1 and BRCA2 mutation carriers is not established, nor is the optimum duration of benefit. An overview of the main outcomes of the current published studies confirms a 38% decrease in breast cancer incidence with Tamoxifen but recommends its use be restricted to women at high risk of breast cancer and low risk for potential side effects. The role of bilateral risk-reducing mastectomy or prophylactic mastectomy has been controversial for several reasons, including the psychosocial significance of the breast in Western cultures, the wide acceptance of breast conservation in surgery for early breast cancer, and the previous lack of data on its efficacy. The surgical procedure should aim to remove substantially all at-risk breast tissue. However, there is a balance between reduction of cancer risk and cosmetic outcome. Bilateral prophylactic oophorectomy can significantly decrease ovarian cancer risk in women who carry BCRA1 mutations. Oophorectomy lowers the risk of breast cancer, even in women who have previously used hormone replacement therapy. There are no published randomized controlled trials examining the effectiveness of mammographic screening in women under 50 years of age with a family history of breast cancer. However, the published studies do suggest that mammographic screening of a high-risk group of women under 50 years of age may detect cancer at a rate equivalent to that seen in women 10 years older with normal risk. Other initial studies also support MRI as having a greater sensitivity than mammography in high-risk women. Breast clinical and self-examination is often advocated, but its effectiveness is unproved, and only one randomized study has been undertaken in women at risk. On the basis of this study as well as one nonrandomized study, it can be concluded that clinical examination as well as mammography are essential in detecting breast cancer. under 50 years of age with a family history of breast cancer. However, the published studies do suggest that mammographic screening of a high-risk group of women under 50 years of age may detect cancer at a rate equivalent to that seen in women 10 years older with normal risk. Other initial studies also support MRI as having a greater sensitivity than mammography in high-risk women. Breast clinical and self-examination is often advocated, but its effectiveness is unproved, and only one randomized study has been undertaken in women at risk. On the basis of this study as well as one nonrandomized study, it can be concluded that clinical examination as well as mammography are essential in detecting breast cancer.

CITED BY
  1. Golubovskaya Vita M., Virnig Christopher, Cance William G., TAE226-Induced apoptosis in breast cancer cells with overexpressed Src or EGFR, Molecular Carcinogenesis, 47, 3, 2008. Crossref

  2. Kaur M., Radovanovic A., Essack M., Schaefer U., Maqungo M., Kibler T., Schmeier S., Christoffels A., Narasimhan K., Choolani M., Bajic V. B., Database for exploration of functional context of genes implicated in ovarian cancer, Nucleic Acids Research, 37, Database, 2009. Crossref

  3. Prochazka M, Hall P, Granath F, Czene K, Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study, British Journal of Cancer, 95, 9, 2006. Crossref

  4. de Melo-Martín Inmaculada, Genetic Testing: The Appropriate Means for a Desired Goal?, Journal of Bioethical Inquiry, 3, 3, 2006. Crossref

  5. Kim Myoung Ok, Kim Sung Hyun, Lee Sang Ryeul, Shin Mi Jung, Min Kwan Sik, Lee Dong Beom, Lee Sung Won, Kim Kil Soo, Kim Sun Jung, Ryoo Zae Young, Ectopic expression of tethered human follicle-stimulating hormone (hFSH) gene in transgenic mice, Transgenic Research, 16, 1, 2007. Crossref

  6. Werner-Lin Allison, Beating the Biological Clock: The Compressed Family Life Cycle of Young Women with BRCA Gene Alterations, Social Work in Health Care, 47, 4, 2008. Crossref

  7. Zhang Wei, Becciolini Aldo, Biggeri Annibale, Pacini Paolo, Muirhead Colin R, Second malignancies in breast cancer patients following radiotherapy: a study in Florence, Italy, Breast Cancer Research, 13, 2, 2011. Crossref

  8. Werner-Lin Allison, Formal and Informal Support Needs of Young Women withBRCAMutations, Journal of Psychosocial Oncology, 26, 4, 2008. Crossref

  9. Al-Sadoon Mohamed K., Abdel-Maksoud Mostafa A., Rabah Danny M., Badr Gamal, Induction of Apoptosis and Growth Arrest in Human Breast Carcinoma Cells by a Snake (Walterinnesia aegyptia) Venom Combined With Silica Nanoparticles: Crosstalk Between Bcl2 and Caspase 3, Cellular Physiology and Biochemistry, 30, 3, 2012. Crossref

  10. Verma Mukesh, Seminara Daniela, Arena Fernando J., John Christy, Iwamoto Kumiko, Hartmuller Virginia, Genetic and Epigenetic Biomarkers in Cancer, Molecular Diagnosis & Therapy, 10, 1, 2006. Crossref

  11. DuPree Beth, Breast Health, in Lifestyle Medicine, Second Edition, 2013. Crossref

  12. Molina-Montes Esther, Pérez-Nevot Beatriz, Pollán Marina, Sánchez-Cantalejo Emilio, Espín Jaime, Sánchez María-José, Cumulative risk of second primary contralateral breast cancer in BRCA1/BRCA2 mutation carriers with a first breast cancer: A systematic review and meta-analysis, The Breast, 23, 6, 2014. Crossref

  13. Pelletier Cory, Speed William C., Paranjape Trupti, Keane Katie, Blitzblau Rachel, Hollestelle Antoinette, Safavi Kyan, van den Ouweland Ans, Zelterman Daniel, Slack Frank J., Kidd Kenneth K., Weidhaas Joanne B., RareBRCA1haplotypes including 3’UTR SNPs associated with breast cancer risk, Cell Cycle, 10, 1, 2011. Crossref

  14. Madeira Klesia Pirola, Daltoé Renata Dalmaschio, Sirtoli Gabriela Modenesi, Carvalho Alex Assis, Rangel Leticia Batista Azevedo, Silva Ian Victor, Estrogen receptor alpha (ERS1) SNPs c454-397T>C (PvuII) and c454-351A>G (XbaI) are risk biomarkers for breast cancer development, Molecular Biology Reports, 41, 8, 2014. Crossref

  15. Gorodetska Ielizaveta, Serga Svitlana, Levkovich Natalia, Lahuta Tetiana, Ostapchenko Ludmila, Demydov Serhyi, Anikusko Nikolay, Cheshuk Valeriy, Smolanka Ivan, Sklyar Svitlana, Polenkov Serhyi, Boichenko Oleksander, Kozeretska Iryna, The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine, Hereditary Cancer in Clinical Practice, 13, 1, 2015. Crossref

  16. Veskimäe Kristina, Staff Synnöve, Tabaro Francesco, Nykter Matti, Isola Jorma, Mäenpää Johanna, Microarray analysis of differentially expressed genes in ovarian and fallopian tube epithelium from risk-reducing salpingo-oophorectomies, Genes, Chromosomes and Cancer, 54, 5, 2015. Crossref

  17. Aleskandarany Mohammed, Caracappa Daniela, Nolan Christopher C., Macmillan R. Douglas, Ellis Ian O., Rakha Emad A., Green Andrew R., DNA damage response markers are differentially expressed in BRCA-mutated breast cancers, Breast Cancer Research and Treatment, 150, 1, 2015. Crossref

  18. Gadducci Angiolo, Biglia Nicoletta, Cosio Stefania, Sismondi Piero, Riccardo Genazzani Andrea, Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy, Gynecological Endocrinology, 26, 8, 2010. Crossref

  19. Verma Kanika, Kannan Kaavya, V Shanthi, R Sethumadhavan, V Karthick, K Ramanathan, Exploring β-Tubulin Inhibitors from Plant Origin using Computational Approach, Phytochemical Analysis, 28, 3, 2017. Crossref

  20. Martínez-Mesa J., Werutsky G., Michiels S., Pereira Filho C.A.S., Dueñas-González A., Zarba J.J., Mano M., Villarreal-Garza C., Gómez H., Barrios C.H., Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region, Public Health, 149, 2017. Crossref

  21. Arroyo Yustos M., Martín Angulo M., Álvarez-Mon Soto M., Cáncer de mama, Medicine - Programa de Formación Médica Continuada Acreditado, 12, 34, 2017. Crossref

  22. Sayani Ambreen, Inequities in genetic testing for hereditary breast cancer: implications for public health practice, Journal of Community Genetics, 10, 1, 2019. Crossref

  23. Al‐Hussaini Maysa, Ammar Khawlah, Kasasbeh Nour, Sultan Hala, Al‐Omari Amal, Global celebrities' effect on health awareness among Jordanians: A study using the case of Angelina Jolie, Journal of Genetic Counseling, 28, 5, 2019. Crossref

  24. Koroth Jinsha, Nirgude Snehal, Tiwari Shweta, Gopalakrishnan Vidya, Mahadeva Raghunandan, Kumar Sujeet, Karki Subhas S., Choudhary Bibha, Investigation of anti-cancer and migrastatic properties of novel curcumin derivatives on breast and ovarian cancer cell lines, BMC Complementary and Alternative Medicine, 19, 1, 2019. Crossref

  25. Ren Boxue, Ye Lei, Gong Jianwei, Ren Huanhuan, Ding Yangfang, Chen Xiaoyu, Liu Xiaona, Lu Peng, Wei Fei, Xu Wenjuan, Zheng Qiusheng, Li Defang, Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer, Frontiers in Pharmacology, 10, 2019. Crossref

  26. Yoshida Reiko, Watanabe Chie, Yokoyama Shiro, Inuzuka Mayuko, Yotsumoto Junko, Arai Masami, Nakamura Seigo, Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X, Oncotarget, 10, 35, 2019. Crossref

  27. Fadda Marta, Chappuis Pierre O., Katapodi Maria C., Pagani Olivia, Monnerat Christian, Membrez Véronique, Unger Sheila, Caiata Zufferey Maria, Galli Alvaro, Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?, PLOS ONE, 15, 10, 2020. Crossref

  28. Kardashian Ani, Fehniger Julia, Creasman Jennifer, Cheung Eleanor, Beattie Mary Stanley, A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome, Hereditary Cancer in Clinical Practice, 10, 1, 2012. Crossref

Forthcoming Articles

Transfer of guided emergence profile developed using customized provisional implant restoration and cementation using an abutment replica technique- A case report. Vinay Sivaswamy, Balaji Anand S D, Jacob Mathew Philip, C J Venkatakrishnan, Narasimman M, Helen Mary Abraham, Pavithra B Marijuana use is Associated with Increased Rates of Hip Dislocation and Lower Insurance Reimbursement among THA Recipients Andrew Recker, Chukwuweike Gwam, Erin Kelly, Scott Douglas, Johannes Plate Surface modification of Mg alloy AZ91D using nanopowder mixed EDM for Biodegradable Implant Alok Kumar, Abhishek Singh The history of orthopedics in the long term: from general medicine to medical specialties Pavlos Altsitzioglou, Ioannis Zafeiris, Fotini Soucacos, Pantelis Limneos, Eleftheria Souliotis, Evanthia Mitsiokapa, Theodosis Saranteas, Andreas Mavrogenis COMPARISON OF ROUGHNESS, WETTABILITY AND SCANNING ELECTRON MICROSCOPY FEATURES BETWEEN SANDBLASTED ACID-ETCHED AND OXIDIZED TITANIUM DENTAL IMPLANTS Kshitiz Chhabra, Arvina Rajasekar CORRELATION BETWEEN PRIMARY STABILITY OF DENTAL IMPLANTS AND BONE DENSITY: A RETROSPECTIVE ANALYSIS Padmaja S, Arvina Rajasekar C-Reactive Protein and Erythrocyte Sedimentation Rates after total and unicompartmental knee arthroplasty - less implant equals quicker normalization Kasım Kılıçarslan, Ömer Faruk Naldöven, Enejd Veizi, Şahan Güven, Şahin Çepni, Ahmet Fırat COMPLICATIONS FOLLOWING SHORT FEMORAL NAIL FIXATION FOR INTETROCHANTERIC HIP FRACTURES. A RETROSPECTIVE STUDY Anastasia Vasilopoulou, Antonios Trichonas, Konstantinos Palaiologos, Emmanouel Antonogiannakis, Christos Nikakis, Stavros Angelis, Spyridon Maris, Christos Grekas , Efthimios Karadimas, Alexandros Apostolopoulos FEA: Connector Designs and Pontic Stress Distribution of Fixed Partial Denture Implant-Supported Metal Framework Saja Muhsin, Enas Mohammed, Khalid Bander Design and Frequency Stability Analysis of an Adaptive Neuro-Fuzzy Inference System based Artificial Pacemaker Controller in MATLAB Nader Jafarnia Dabanloo, Asghar Dabiriaghdam, Fereidoon Nooshirvan Rahatabad, Keivan Maghooli Complications following intraosseous injections of calcium phosphate bone cement in Subchondroplasty. Christos Zachariadis, Helen Leligou, Stauros Kourkoulis, Evaggelos Magnisalis, Panayiotis Papagelopoulos, Olga Savvidou The Impact of Patient Characteristics on Outcomes of Surgically Managed Vertebral Osteomyelitis in the United States: Insights from a National Database Study Jennifer Kurowicki, Stuart Changoor, Daniel Coban, Neil Patel, Kumar Sinha, Ki Hwang, Arash Emami ASSOCIATION OF AGE, GENDER AND SITE OF IMPLANT PLACEMENT - AN INSTITUTION BASED RETROSPECTIVE STUDY Harini Sri, Nabeel Ahmed, Keerthi Shasanka
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain